Safety signals concerning asthma drugs in children

E. Baan (Rotterdam, Netherlands)

Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Session: Small airways, long distances and large databases in paediatric asthma
Session type: Oral Presentation
Number: 3447
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Baan (Rotterdam, Netherlands). Safety signals concerning asthma drugs in children. 3447

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of asthma medication by two sources of information in children and adolescents
Source: Eur Respir J 2007; 30: Suppl. 51, 299s
Year: 2007

Safety and efficacy of omalizumab in children with allergic asthma
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Evidence that children can assess their asthma medication devices
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011


Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Safety of omalizumab therapy in children with allergic asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Monitoring asthma in children
Source: Eur Respir J 2015; 45: 906-925
Year: 2015



Monitoring asthma in children
Source: Guideline 2015
Year: 2015

Safety of tiotropium in pre-school children with symptomatic persistent asthma
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Efficacy and patient/parent preference of asthma medication delivery systems in children and adolescents
Source: Eur Respir J 2003; 22: Suppl. 45, 474s
Year: 2003

Monitoring asthma in children: clinical tools
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Rescue/acute and allergy medication use among children on asthma controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004

Safety of once-daily QMF149 in patients with persistent asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012


Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021



Safety of inhaled corticosteroids reduction in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Prescription of asthma medications in preschool children across Norwegian counties
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Efficiency of the modern combined drugs in complex treatment of the asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 312s
Year: 2003